In Saccharomyces cerevisiae the UPF1 protein is required for nonsense-mediated mRNA decay, the accelerated turnover of mRNAs containing a nonsense mutation. Several lines of evidence suggest that translation plays an important role in the mechanism of nonsense mRNA decay, including a previous report that nonsense mRNAs assemble in polyribosomes. In this study we show that UPF1 and ribosomal protein Li co-localize in the cytoplasm and that UPF1 co-sediments with polyribosomes. To detect UPF1, three copies of the influenza hemagglutinin epitope were placed at the C-terminus. The tagged protein, UPF1-3EP, retains 86% (+ 5%) of function. Using immunological detection, we found that UPF1-3EP is primarily cytoplasmic and was not detected either in the nucleus or in the mitochondrion. UPF1-3EP and Li co-distributed with polyribosomes fractionated in a 7-47% sucrose gradient. The sucrose sedimentation profiles for UPF1-3EP and Li exhibited similar changes using three different sets of conditions that altered the polyribosome profile. When polyribosomes were disaggregated, UPF1-3EP and Li accumulated in fractions coincident with 80S ribosomal particles. These results suggest that UPF1-3EP associates with polyribosomes. L3 and S3 mRNAs, which code for ribosomal proteins of the 60S and 40S ribosomal subunits, respectively, were on average about 100-fold more abundant than UPF1 mRNA. Assuming that translation rates for L3, S3, and UPF1 mRNA are similar, this result suggests that there are far fewer UPF1 molecules than ribosomes per cell. Constraints imposed by the low UPF1 abundance on the functional relationships between UPF1, polyribosomes, and nonsense mRNA turnover are discussed.
INTRODUCTION
Messenger RNA abundance is determined by the relative rates of mRNA synthesis and decay. Regulation often occurs at both levels to achieve the flexibility needed for a rapid cellular response to environmental changes or developmental programs (Sachs, 1993) . Although much more is currently known about transcriptional regulatory mechanisms, the general fea-would prevent the accumulation of potentially deleterious truncated proteins. In addition, these pathways may also control the steady state levels of some specific mRNAs as suggested by Leeds et al. (1991) .
Nonsense mRNAs appear to be targeted for accelerated decay due to premature translational termination, implying that mRNA decay pathways of this type act in concert with translation. Functional coupling of translation and nonsense mRNA decay is further suggested by the observation that efficient tRNA nonsense suppressors restore stability to nonsense mRNAs (Losson and Lacroute, 1979; Gozalbo and Holmann, 1990; Belgrader et al., 1993) . Hairpin structures inserted in the 5'-untranslated region of mRNA that reduce the rate of translational initiation restore stability to nonsense mRNA (Belgrader et al., 1994) . Also, nonsense mRNAs that are subject to accelerated decay are found to be associated with polyribosomes that are actively engaged in translation (Leeds et al., 1991) .
In S. cerevisiae, studies of the UPF1 and UPF3 genes have led to new insights into the mechanism of nonsense mRNA decay (Leeds et al., 1991 (Leeds et al., , 1992 . In strains lacking a functional UPF1 or UPF3 product, the decay rate of nonsense mRNA is restored to a level comparable to the corresponding wild-type mRNA, but the half-life of the wild-type mRNA remains unaltered. Unlike tRNA suppressors that were shown to stabilize nonsense mRNAs by promoting translational readthrough of a premature stop codon (Losson and Lacroute, 1979) , loss of UPF1 function does not appear to enhance read-through (Leeds et al., 1991) . These results suggest that despite the dependence of nonsense mRNA decay on efficient premature translational termination, the UPF1 product does not stimulate decay merely by ensuring efficient termination. Considering that upfl -cells are also hypersensitive to cycloheximide, an inhibitor of translational elongation, it seems likely that one or more of the UPF gene products will be found to interact directly with ribosomes actively engaged in translation.
Although nonsense mRNA decay may be triggered in physical proximity with cytoplasmic ribosomes, recent studies in mammals suggest that a complex mechanism is possible. Cheng and Maquat (1993) measured the accumulation of human TPI mRNA and found that nonsense mutations reduced the accumulation of both nuclear and cytoplasmic mRNA pools. If decay occurred in the cytoplasm, one would have expected a decrease in the cytoplasmic mRNA pool only. This result could not be explained by any observed differences in rates of transcription or processing of nuclear pre-mRNA or in the rate of cytoplasmic mRNA decay. The results could, however, be explained if the decay pathway is nuclear-associated. For example, nonsense mutations that are utilized during translation in the cytoplasm could trigger decay during transport of the mRNA from the nucleus to the cytoplasm (Belgrader et al., 1993 (Belgrader et al., , 1994 . This implies that nuclear export and translation may be spacially and temporally coupled, a possibility that remains to be verified experimentally.
One way to see where nonsense mRNA degradation takes place is to determine where gene products that catalyze steps in the pathway localize. At present there is no definitive proof that any of the UPF gene products directly catalyze steps in the pathway. However, we regard UPF1 as a good candidate for direct participation, based on the phenotypes of both dominant and recessive alleles of UPF1, and on the presence of structural motifs in the amino acid sequence that suggest a potential for interaction with RNA. We have addressed the question of where UPF1 localizes by developing an immunological detection system for UPF1 based on epitope tagging. Our evidence suggests that yeast UPF1 is present in low abundance throughout the cytoplasm, but is below the limits of cytochemical detection in the nucleus and the mitochondrion. UPF1 has sedimentation properties in sucrose gradients suggesting an association with polyribosomes. The possible functional relationships between the association of UPF1 with polyribosomes and the possible roles of LTPF1 and polyribosomes in nonsense mRNA decay are discussed.
MATERIALS AND METHODS

Strains and Genetic Methods
The S. cerevisiae strains used in this study are described in Table 1 . Strains were constructed using standard yeast genetic techniques (Rose et al., 1990) . Media for growth and maintenance of yeast was described by Gaber and Culbertson (1982) . Yeast transformations were performed using the method of Ito et al. (1983) as described by Ausubel et al. (1993) . Escherichia coli strain DH5a was used for preparation of plasmid DNAs. Methods for growth, maintenance, and transformation of bacteria are described by Sambrook et al. (1989) .
Nucleic Acid Methods
Plasmid DNA was prepared from E. coli by the method of Bimboim and Doly (1979) as described by Sambrook et al. (1989) . DNA sequence analysis was performed by the method of Sanger et al. (1977) using the Sequenase 2.0 kit (United States Biochemical, Cleveland, OH). RNA prepared for Northern analysis was isolated by hot phenol extraction as described by Leeds et al. (1991) . RNA/DNA hybridizations were carried out by Northern blotting. Total RNA was resolved on 1.0% agarose/formaldehyde gels and blotted onto GeneScreen Plus membranes using the capillary blot protocol recommended by the manufacturer (DuPont, NEN Products, Boston, MA). Hybridization conditions were as described by Klessig and Berry (1983) , except that 1.0% sarkosyl was used in the prehybridization and hybridization buffers. DNA probes were prepared from restriction fragments resolved on low-melting point agarose gels and oligolabelled by the method of Feinberg and Vogelstein (1983) using an oligolabelling kit (Pharmacia Biotech, Piscataway, NJ) and [a32PJdCTP (3000Ci/mmol; Amersham, Arlington Heights, IL).
Construction of UPF1-3EP
The influenza virus hemagglutinin (HA) epitope was placed at the C-terminus of UPF1 by in vitro construction of an allele designated UPF1-3EP. A 114-bp NotI fragment coding for three copies of the nine-amino acid long HA epitope was isolated after NotI digestion of plasmid GTEPI (Roof et al., 1992) . The NotI fragment was placed at the 3' end of UPF1 by first creating a NotI site between the last sense codon and the termination codon. To accomplish this, a 1473-bp SspI fragment with end points inside the UPF1 coding region was deleted from a pUC19 sub-clone that carried the full length UPF1 gene (designated pUC19UPFlASspI). Primers 5'-CCC GCG GCC GCC TAT TCC CAA ATT GCT GAA GTC-3' and 5'-CCC GCG GCC GCT AAT TCG GTG AAC CCT GTT AA-3' were used in polymerase chain reaction (Ausubel et al., 1993) to create the NotI site between the last sense codon and the stop codon of UPF1ASspI. Polymerase chain reaction products were analyzed by DNA sequence analysis. The NotI fragment coding for the HA epitope was subcloned into the newly introduced NotI site of UPF1ASspI by standard subcloning procedures. A NruI-BamHI fragment of UPF1 DNA containing the NotI insert was used to replace the wild-type NruI-BamHI fragment in the UPFI gene carried on plasmid pRS316, resulting in plasmid pRS316UPF1-3EP. Subsequently, an EcoRIBamHI fragment from pRS316UPF1-3EP containing UPF1-3EP was subcloned into pRS314 and pRS315, resulting in plasmids pRS314UPF1-3EP and pRS315UPF1-3EP. pRS314, pRS315, and pRS316 are centromeric plasmids carrying the yeast TRP1, LEU2, and URA3 selectable markers, respectively (Sikorski and Hieter, 1989) .
Protein Methods
Total protein extracts from yeast were prepared as follows: cultures were grown in 40 ml of -Ura medium at 30°C to a final OD6. of 0.6. Cells were pelleted at 8000 x g for 10 min and then washed in 10 ml of lysis buffer (5 mM EDTA, 250 mM NaCl, 0.1% Nonidet P-40, 50 mM Tris HCl, pH 7.4, 4°C). The cell pellet was resuspended in 0.8 ml of lysis buffer plus protease inhibitors (0.1 mM phenylmethylsulfonyl fluoride (PMSF), 1 ,ug/ml aprotinin, 1 ,ug/ml pepstatin A, 1 ,tg/ml chymotrypsin, 1 ,ug/ml leupeptin, and 1 ,g/ml antipain). The cell slurry was divided between two 1.5-ml Eppendorf centrifuge tubes, and lysed with ice cold, acid-washed glass beads by continuous vortexing for 3 min at 4°C. The supernatant was recovered and then cleared by centrifugation for 20 min at 4°C. The amount of protein in the cell lysates was quantitated using a BCA protein quantitation kit (Pierce, Rockford, IL). Twenty micrograms of protein was used for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
For Western blotting, SDS-PAGE and electrophoretic transfer to nitrocellulose were done using a Bio-Rad Mini-Protean apparatus (Bio-Rad, Hercules, CA) as described by Bollag and Edelstein (1991) . Western blotting was done using the ECL Western blotting detection system (Amersham) or as described by Bollag and Edelstein (1991) 
Indirect Immunofluorescent Microscopy
Ten milliliter cultures of yeast were grown to mid-log phase (OD600 = 0.4-0.7) in medium to select for the presence of plasmids carrying the UPF1-3EP gene. Next, 1.4 ml of 37% formaldehyde was added and the culture was incubated at 37°C for 5 min with gentle shaking. The culture was then allowed to sit at room temperature for 1 h. The cells were pelleted for 2 min at 300 x g and then washed three times in 3 ml of buffer 1 (1.2 M sorbitol, 0.1 M potassium phosphate, pH 6.5, 1% 13-mercaptoethanol). Cells were resuspended in 0.5 ml of buffer 1 and 50 U of lyticase was added followed by incubation for 9 min at 30°C with gentle shaking. The cells were pelleted and washed twice with 3 ml of buffer 2 (1.2 M sorbitol, 0.1 M potassium phosphate, pH 6.5). Cells were resuspended in buffer 2 to approximately A6o0 = 5.0/ml. Cells (60 ,l) were spotted onto slides pretreated with 1% polyethyleneimine. The cells were allowed to settle for 30 min and then the slides were rinsed twice in phosphatebuffered saline (PBS). The slides were then immersed in methanol (pre-chilled to -20°C) for 6 min followed by immersion in acetone (chilled to -20'C) for 30 s. Slides were air dried. Cells were blocked with 30 ,ul of blocking buffer (1% bovine serum albumin and 0.05% Nonidet P-40 in PBS) for 15 min at room temperature. Thirty microliters of PBS containing the primary antibodies was added and the slides were incubated overnight at room temperature. Slides were washed twice in 0.5% Nonidet P-40, PBS and then three times in PBS. The cells were blocked again as described above, followed by the addition of 30 ,lI of PBS containing the secondary antibodies. The slides were incubated for 1 h at room temperature and then washed as previously described. The DNA was stained with 4,6-diamidino-2-phenylindole (DAPI) by adding 30 
Cell Fractionation
Cells were fractionated and a crude ribosome pellet was prepared using the method of Grant et al. (1974) with modifications from Sachs and Davis (1989) . Part of the cell lysate (150 ,ul) was reserved as a total cellular extract. The remaining 1 ml cell lysate was centrifuged at 5,000 x g for 5 min. The supernatant (cytosol-enriched fraction) was transferred to a fresh tube and the pellet was resuspended in 1 ml of Laemmli buffer supplemented with 4.5 M urea.
The ribosomes were pelleted from 600 ,ll aliquots of the cytosolenriched fraction by centrifugation at 160,000 x g for 90 min. The supernatant was transferred to a fresh Eppendorf tube, and the pellet was resuspended in 600 pl of Laemmli buffer supplemented with 4.5 M urea.
Cells were fractionated into mitochondrial and post-mitochondrial fractions essentially as described by Herbert et al. (1988) , except that crude mitochondria were washed four times in the presence of 1 mM PMSF followed by two washes in the absence of PMSF. Vol. 6, May 1995 613 Mitochondria were treated with 0.2 mg/ml proteinase K for 30 min on ice. Where indicated, mitochondria were solubilized by addition of Triton X-100 to 0.5%. Proteinase K digestion was terminated by adding PMSF to 1 mM.
Polyribosome Analysis
Polyribosomes were prepared and fractionated as described by Deshmukh et al. (1993) detector (Lincoln, NE) equipped with a density gradient flow cell. Fractions (0.5 ml) were collected using an ISCO Foxy Jr. fraction collector. The proteins in the fractions were acetone precipitated, and then resuspended in 10 ,ul of Laemmli buffer supplemented with 4.5 M urea. Samples were fractionated by SDS-PAGE and transferred to membranes for Western blotting using the ECL Western blotting detection system (Amersham). The bands on autoradiographs of the Western blots were quantitated using a Model 300A computing densitometer (Molecular Dynamics, Sunnyvale, CA). Hyperfilm ECL (Amersham) was pre-flashed before autoradiography and only bands within the linear dynamic range were quantitated. The density of the bands on autoradiographs and the concentration of protein in the bands is not directly proportional because the emission of light from ECL Western blots is nonlinear. As a consequence of this, the peak accumulation of protein is underestimated using this technique.
RESULTS
The aim of this study was to determine the intracellular localization of UPF1. Using immunological detection, we determined localization by three methods: indirect immunofluorescence, cell fractionation, and distribution relative to polyribosomes fractionated in a sucrose gradient. To detect UPF1 in these experiments, the wild-type gene was modified by placing a DNA sequence immediately 5' to the normal termination codon that codes for three tandem copies of the 12CA5 influenza virus HA epitope (see MATE-RIALS AND METHODS). The modified gene, designated UPF1-3EP, was subcloned into centromeric plasmids and introduced into strains PLY38, BJ2168, and PLY102 (Table 1 ). PLY38 and PLY102 both lack a functional UPF1 gene. BJ2168 carries a wild-type UPF1 gene. The experiments described below were performed using these strains.
A C-Terminal Epitope-tagged UPF1 Product Is Functional In Vivo The ability of UPF1-3EP to provide wild-type UPF1 function in vivo was tested using a frameshift allosuppression assay described previously in which the rate of growth on medium lacking histidine is sensitive to the turnover rate of his4-38 mRNA (Culbertson et al., 1980; Leeds et al., 1991) . Strains wild type for the UPF (up frameshift) genes and carrying both his4-38 and SUF1-1 have a His' phenotype at 30°C, but these cells remain His-at 37°C. Mutations in UPF confer a His'
phenotype at 37°C through restabilization of his4-38 mRNA. Using this assay ( Figure 1A ), we found that the growth of strain PLY38[pRS316UPF1-3EPI at 37°C was somewhat faster but very similar to strain PLY38[pRS316UPF1I. However, strain PLY38-[pRS3161, which lacks both UPF1 and UPF1-3EP, grew rapidly to confluency at 37°C. These growth tests indicate that UPF1-3EP confers nearly complete complementation of the loss of wild-type UPF1 function.
The function of UPF1-3EP was compared with UPF1 using quantitative Northern blotting to determine the effect of each gene on his4-38 mRNA accumulation. The relative levels of his4-38 mRNA accumulation in strain PLY38 transformed separately with pRS316, pRS316UPF1, and pRS316UPF1-3EP were 1.0, 0.47 (± 0.03), and 0.55 (± 0.06), respectively. Thus, UPF1-3EP reduced his4-38 mRNA accumulation 86% (+ 5%) as well as the wild-type UPF1 protein. Because 
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MATa his3-11 leu2-3,112 ade2-1 ura3-1 trpl-1 canl-100 UPF1 (rho+, mit+) Altamura et al., 1994 CNA MATa his3-11 leu2-3,112 ade2-1 ura3-1 trpl-1 canl-100 upfl-A3 (rho+, mit+) Altamura et al., 1994 aThe mutation in upfl-2 is a single nucleotide change at nucleotide +615 that changes a UGG Trp codon to a UGA nonsense codon. This allele of UPF1 has a phenotype that is indistinguishable from a null allele of UPFI (Leeds et al., 1992) . Growth tests were performed to assess the ability of UPF1-3EP to compensate for loss of wild-type UPF1 function. Strains carrying the suppressible frameshift mutation his4-38 (Donahue et al., 1981) , the tRNA frameshift suppressor SUF1-1 (Mendenhall et al., 1987) , and a wild-type UPF1 gene fail to grow at 37°C on -histidine medium due to destabilization of his4-38 mRNA (Leeds et al., 1991) . Equivalent strains carrying a UPF1 loss-of-function mutation grow at 37'C on -histidine medium due to re-stabilization of his4-38 mRNA (Culbertson et al., 1980; Leeds et al., 1991) . Strain PLY38, which carries the upfl-2 allele (Table 1) , was separately transformed with three centromeric plasmids carrying the yeast URA3 gene: pRS316 (no UPF1 gene), pRS316UPF1 (wild-type UPF1 gene), and pRS316UPF1-3EP (epitope-tagged UPF1 gene). Growth of the resulting transformants was tested by plating 100, 10-1, 10-2, and 10-3 serial dilutions of overnight cultures on -Ura and -Ura -His medium at 30'C and 37'C. his4-38 mRNA accumulation is proportional to halflife in PLY38 transformants (Leeds et al., 1991) , the levels of accumulation reflect how well UPF1-3EP promotes nonsense mRNA decay. Furthermore, the UPF1-3EP phenotype is recessive to wild type, indicating that the modestly reduced function of UPF1-3EP could result from a reduction in the amount of UPF1 protein or a partial loss of function. Based on these results, the behavior of UPF1-3EP is expected to resemble that of the wild-type UPF1 protein and is therefore suitable for localization studies.
Molecular Biology of the Cell
The product of the UPF1-3EP gene was detected as a single band with an approximate molecular weight of 113 k on a Western blot of protein from strain BJ2168[pRS316UPF1-3EPI probed with 12CA5 antibodies ( Figure 1B) . The estimated molecular weight of this band based on its migration in SDS-polyacrylamide gels relative to molecular weight standards agrees well with the molecular weight for UPF1-3EP predicted from the DNA sequence. This band was not detected in protein derived from strain BJ2168- [pRS316] , which lacks the UPF1-3EP gene. These results suggest that the observed band is the product of the UPF1-3EP gene. No other bands are detectable using the Western blotting conditions described in MATERIALS AND METHODS. To further substantiate these conclusions, a peptide competition experiment was performed. Increasing concentrations of free peptide containing the 12CA5 epitope diminished the 113-k signal on Western blots. Therefore, the observed band results from the recognition of UPF1-3EP by 12CA5 antibodies (our unpublished observations).
As a final test of the experimental system, we performed indirect immunofluorescent microscopy using 12CA5 antibodies. Strain PLY102[pRS314UPF1-3EPI gave a visible fluorescent signal, whereas PLY102-[pRS316] did not (our unpublished observations). This result indicates that background fluorescence was sufficiently low to allow cells expressing UPF1-3EP to be used to localize the protein.
UPF1-3EP Is Cytoplasmic UPF1-3EP was localized by indirect immunofluorescence in cells double-labeled with antibodies against UPF1-3EP and Li, a SEN1::,Bgal fusion, KAR2, or MAS2. Li, a component of the 60S ribosomal subunit (Deshmukh et al., 1993) , is located primarily in the cytoplasmic ribosomes. A small amount of Li is also found in the nucleolus where ribosomal subunits are assembled. SEN1::P3gal localizes to the nucleus (Ursic, DeMarini, and Culbertson, unpublished data; DeMarini et al., 1992) . KAR2 localizes to the endoplasmic reticulum (ER) (Rose et al., 1989) . Because the ER is contiguous with the nuclear membrane in yeast, fluorescence due to KAR2 often forms a ring that marks the boundary between the cytoplasm and the nucleus (Rose et al., 1989) . Eighty percent of the cells stained with KAR2 antibodies had a ring marking the boundary between the cytoplasm and the nucleus (our unpublished observations). MAS2 is found in the mitochondrial matrix (Jensen and Yaffe, 1988 with LI, SEN1::,gal, KAR2, and MAS2 (Figure 3 ). 12CA5 antibodies were used to visualize UPF1-3EP using fluorescein-conjugated secondary antibodies (Figure 3, left column) . These cells appear to stain mostly green, but with some regions where no staining is visible. To determine if the unstained regions correspond to the nuclei, we examined overlays of images showing UPF1-3EP staining with images of rhodamine-stained SENl::4gal or KAR2 (red) ( Figure  3 , B and C). Any overlap in staining pattern appears as yellow. Very little overlap in the staining pattern of UPF1-3EP and SEN1::3gal or KAR2 was observed, indicating that there is little or no detectable UPF1-3EP in the nucleus. Also, there was very little overlap in the staining pattern of UPF1-3EP and MAS2, the mitochondrial matrix protein ( Figure 3D ). In contrast, an intense yellow color indicates significant overlap in distribution between UPF1-3EP and ribosomal protein LI ( Figure 3A) . We cannot rule out the possibility that there may be small amounts of UPF1-3EP in the nucleus, ER, or mitochondria, but if (Table 1) was transformed with centromeric plasmid pRS314UPFl-3EP.
Cells were stained with DAPI (bottom row: A3, B3, C3, and D3) and with 12CA5 antibodies that recognize UPFl-3EP (top row: Al, Bi, Cl, and Dl). The middle row shows cells stained with antibodies that recognize Li (A2), SENl::I3gal (B2), KAR2 (C2), and MAS2 (D2). LI is primarily localized in the cytoplasm, SEN::,3gal in the nucleus, KAR2 in the endoplasmic reticulum, and MAS2 in the mitochondrion (Jensen and Yaffe, 1988; Rose et al., 1989; Deshmukh et al., 1993;  Ursic, DeMarini, and Culbertson, unpublished data). The SEN1::f3gal fusion, which is expressed from a GALl promoter on a 2 ,u plasmid, was induced by pre-growth in raffinose followed by growth in galactose-containing medium. Bar, 5 mm.
Molecular Biology of the Cell 616 Figure 3 . The distribution of UPF1-3EP overlaps with ribosomal protein LI. Strain PLY102 (Table 1) , was transformed with the centromeric plasmid pRS314UPF1-3EP. Cells were stained with 12CA5 antibodies that recognize UPF1-3EP using fluorescein-conjugated secondary antibodies (first column, green) and with antibodies that recognize LI (A2), (3-gal (B2), KAR2 (C2), or MAS2 (D2) using rhodamine-conjugated secondary antibodies (second column, red). Staining was visualized by confocal microscopy. Single images from the first and second columns were overlaid to determine the extent of co-distribution [UPF1-3EP and LI (A3), SEN1::,gal (B3), KAR2 (C3), and MAS2 (D3)]. The regions of co-localization appear as yellow. Bar, 2 mm. present in these compartments it must be at concentrations below the level of detection using this approach.
UPF1-3EP Fails to Accumulate in Mitochondria
The UPEl gene isolated by Leeds et al. (1992) on the basis of allo-frameshift suppression (Leeds et al., 1991) was also identified as NAM7 by Altamura et al. (1992) in a screen for multi-copy suppressors of a mitochondrial splicing-deficient mutation (Ben Asher et al., 1989) . Although UPF1 is not essential for growth in glucose-containing medium (Leeds et al., 1992) , loss of UPF1 function causes respiratory impairment and slow growth in lactate-containing medium (Altamura et al., 1992) (Figure 4A ). These results suggest a potential function for UPF1 in the mitochondrion. To investigate this observation further, cell lysates were fractionated using a method that separates the mitochondria from the cytoplasm (see MATERIALS AND METHODS). The fractions were examined by Western blotting using antibodies that recognize UPF1-3EP, the mitochondrial matrix protein Hsp6O, MIT, 30 ,tg of the mitochondrial fraction; CYT, 113 ,ug of the post-mitochondrial fraction. Lanes in panel C were loaded with 100 ,ug of the mitochondrial fraction treated as follows: Lane 1, untreated; lane 2, addition of 0.2 mg/ml proteinase K; lane 3, solubilization in 0.5% Triton X-100 followed by the addition of 0.2 mg/ml proteinase K. and the cytoplasmic protein Hexokinase ( Figure 4B ). Most of the detectable Hsp6O and a small amount of Hexokinase were found in the mitochondrial fraction, whereas no Hsp6O and the majority of Hexokinase were found in the cytoplasmic fraction. The fractionation of UPF1-3EP resembled that of Hexokinase. Mitochondria were treated with proteinase K to determine whether the small amount of UPF1-3EP in the mitochondrial fraction is located inside or outside of the mitochondrion. After proteinase K treatment of the mitochondrial fraction, UPF1-3EP was no longer detectable, whereas Hsp6O was readily detected ( Figure 4C ). This shows that UPF1-3EP is outside the mitochondrion. The lack of growth on lactate-containing medium, which is indicative of respiratory impairment, probably is an indirect consequence of UPF1 function outside the mitochondrion.
UPF1-3EP Is Associated with Polyribosomes
Cell fractionation experiments indicated that a significant portion of the detectable UPF1-3EP co-fractionates with LI, and hence, with ribosomes (our unpublished observations). To determine whether UPF1-3EP is specifically associated with ribosomes, its distribution was compared with the distribution of Li in polyribosomes fractionated in a 7-47% sucrose gradient (see MATERIALS AND METHODS and Figure 5 ). Protein extracts were prepared from cells grown in -Trp synthetic medium to select for the presence of the plasmid carrying UPF1-3EP. To arrest translational elongation, 50 ,ug/ml cycloheximide was added to the growth medium immediately before harvesting the cells. Cycloheximide was also included at the same concentration in the lysis buffer to prevent ribosome runoff during extract preparation. The extracts were resolved into 40S and 60S ribosomal subunits, 80S ribosomal particles, and polyribosomes ( Figure 5A ). Western blots prepared from fractions recovered from the sucrose gradients were sequentially labeled with antibodies to detect UPF1-3EP and Li. Autoradiographs of the blots were quantitated using the ECL Western blotting detection system (Amersham). Light emission by ECL is nonlinear, consequently the peak . These fractions include the 60S ribosomal subunits, the 80S particles and the polyribosomes. In the fractions 8-24+P that contain the 80S ribosomal particle and the polyribosomes, UPF1-3EP and Li have a very similar distribution. These results indicate that a significant proportion of UPF1-3EP is part of a high molecular weight aggregate or complex that co-distributes with polyribosomes. Strains carrying a upfl -null mutation are hypersensitive to cycloheximide (Leeds et al., 1992) . To test the possibility that the addition of cycloheximide to the growth medium and the lysis buffer affects the sedimentation profile of UPF1-3EP, extracts were prepared using a range of cycloheximide concentrations. Using 25-50 ,ug/ml cycloheximide, the A254 profile and the distribution of UPF1-3EP across the sucrose gradient resembled the profile and distribution shown in Figure 5A . In the presence of 100-200 ,tg/ml cycloheximide, the A254 profiles were unaltered but the amount of UPF1-3EP distributed across the gradient appeared to be reduced (our unpublished observations). These results indicate that 50 ,ug/ml cycloheximide can be used in the preparation of polyribosomes without significantly affecting the distribution of UPF1-3EP.
Conditions known to affect the distribution of polyribosomes on sucrose gradients also affected the distribution of UPF1-3EP and Li. In Figure 5B , cycloheximide was omitted during polyribosome preparation. The omission of cycloheximide allows translation on the polyribosomes to be completed (Ramirez et al., 1991) . Because new rounds of initiation are infrequent during cell harvest and extract preparation, 80S ribosomes and the 40S and 60S subunits accumulate at the expense of polyribosomes (Ramirez et al., 1991) . The majority of the ribosomal subunits were present in 80S particles as judged by the A254 profile, but detectable amounts of polyribosomes remained intact, as judged from the A254 profile and the fact that 45% of Li was still found in the fractions containing the polyribosomes (14-24+P). Similar amounts of UPF1-3EP also extend into the polyribosome region of the gradient.
The amounts of UPF1-3EP and Li in fractions 14-24+P were each reduced by about 20% compared with extracts prepared in the presence of cycloheximide. The remainder of UPF1-3EP and Li was detected in fractions 8-13, which contain the 40S and 60S ribosomal subunits and the 80S ribosomal particles. In the absence of cycloheximide, very little UPF1-3EP or Li was observed in fractions near the top of gradient. Thus, UPF1-3EP and Li have very similar distributions.
Cell extracts isolated in the presence or absence of cycloheximide ( Figure 5 , C and D) were treated with 0.5 mg/ml RNase A before fractionation to disrupt the polyribosomes. Using these conditions the majority of the ribosomes were present in 80S particles as judged by the A254 profile. Western blots show that the majority of Li accumulates at a position coincident with the 80S particles. Only 15-20% of Li migrates in the polyribosome region (fractions 14-24+P). Similarly, only about 10% of UPF1-3EP migrated into this region of the gradient. Two separate regions of peak accumulation were observed for UPF1-3EP. One corresponds to monomers, small aggregates, and complexes (about 55% in fractions 1-7 irrespective of the presence or absence of cycloheximide). The other peak location was coincident with the 40S and 60S ribosomal subunits and the 80S ribosomal particle (about 35% in fractions 8-13 irrespective of the presence or absence of cycloheximide). Overall, RNase A treatment results in a 65-85% reduction in the amount of UPF1-3EP and Li found in fractions where polyribosomes migrate. A commensurate increase in accumulation of these proteins was observed in fractions containing monomers, smaller molecular weight aggregates and complexes, 40S and 60S ribosomal subunits, and 80S ribosomal particles.
Growth conditions affect the relative ratio of 80S ribosomal particles to polyribosomes. Cells grown in -Trp synthetic medium were shifted to YEPD medium for two cell generations before extraction in the presence of 50 jig/ml cycloheximide ( Figure 5E ; MA-TERIALS AND METHODS). Under these nonselective conditions, 75% of the cells retained the plasmid carrying UPF1-3EP. Polyribosomes accumulate at the expense of 80S ribosomal particles as judged by the A254 profile and the distribution of Li. About 80% of the Li was detected in the polyribosome fractions (14-24+P), whereas 75% of UPF1-3EP was detected in these fractions. Growth in YEPD results in a 30% and a 20% increase in the amounts of Li and UPF1-3EP, respectively, in polyribosome fractions compared with growth in -Trp synthetic medium. Approximately 5% of UPF1-3EP was found in fractions 1-7 where monomers and small complexes migrate and 20% in fractions 8-13 where the 40S and 60S ribosomal subunits and 80S ribosomal particles migrate. Compared with Figure 5A , these results demonstrate that UPF1-3EP and Li exhibit a similar shift in distribution in the polyribosome region when cells are grown in medium that supports rapid growth. (Fried and Warner, 1981) . In yeast, ribosomal protein gene expression is coordinately controlled to ensure equimolar accumulation (reviewed in Woolford and Warner, 1991) . Because coordinate control is predominantly transcriptional, we expect that the accumulation of mRNAs encoding different ribosomal proteins will be roughly equivalent and proportional to the accumulation of 40S and 60S ribosomal subunits and 80S ribosomes. Assuming that the mRNAs are all translated at similar rates, the relative ratios of UPF1, S3, and L3 mRNA should give an indication of UPF1 abundance relative to ribosomes. To compare levels of mRNA accumulation, total RNA extracted from strain PLY22 (Table 1) during early, middle, and late logarithmic growth was probed by Northern blotting. PLY22 carries the intron-less UPF1, SUF14, and TCM1 genes in single copy at their normal chromosomal locations. The length and G+C content of uniformly labeled DNA probes from the coding regions of each gene were as follows: UPF, 2305-bp, 39.5% G+C; SUF14, 652-bp, 44.0% G+C; TCM1, 1097-bp, 43.8% G+C. The amount of radioactivity detected in the DNA/RNA hybrids, which corresponded to visible bands detected by autoradiography, was adjusted for probe length as described in Table 2 . The effects of small differences in G+C content were considered negligible.
The results of Northern blotting indicate that UPF1 mRNA is much less abundant than S3 or L3 mRNA ( Table 2) . The average accumulation ratios for S3/UPF1 and L3/UPF1 mRNA are approximately 120 and 90, respectively. The S3/L3 mRNA ratio was 1.3, close to a theoretically expected ratio of 1.0. These results indicate that UPF1 mRNA accumulates at a much lower level than two ribosomal protein mRNAs. On this basis, we suggest that the UPF1 protein may be relatively nonabundant compared with ribosomes.
Based on the changes in distribution observed for UPF1-3EP and LI using three different sets of conditions that alter the polyribosome profile, we suggest that UPF1-3EP associates with polyribosomes.
The Relative Abundance of UPF1 Given the evidence that UPF1-3EP associates with polyribosomes, we wanted to estimate the ribosome/UPF1 molar ratio. Because no tools are DISCUSSION UPF1 Is Located Primarily in the Cytoplasm We anticipated that UPF1 might be located in one or more of several different intracellular compartments, including the cytoplasm, the nucleus, or the mitochondrion.
A cytoplasmic location was suggested by evidence that nonsense mRNAs subject to UPFl-mediated decay are found in polyribosomes, which are primarily cytoplasmic (Leeds et al., 1992) . Furthermore, the nonsense mRNA decay pathway is triggered by premature translational termination, suggesting that translation, which is primarily a cytoplasmic event, plays a role in decay. A nuclear location either for UPF1 or the decay pathway itself was also considered possible. UPF1 could influence the rate of nonsense mRNA decay indirectly by affecting ribosome structure from a location in the nucleolus where ribosomal subunits are assembled. Furthermore, recent studies in mammals have led to the suggestion that nonsense mRNA decay may be initiated by translation of nonsense mRNAs that are still in the process of being transported from the nucleus to the cytoplasm (Belgrader et al., 1993 (Belgrader et al., , 1994 Cheng and Maquat, 1993) .
A role for UPF1 in the mitochondrion was suggested by results showing that over-expression of UPF1 from a multi-copy plasmid suppresses a mitochondrial mRNA splicing defect (Ben Asher et al., 1989; Altamura et al., 1992) . Also, loss of UPF1 function confers a reduced rate of growth in medium containing lactate as a sole carbon source, suggesting a requirement for UPF1 in respiratory processes that occur in the mitochondria.
To find out where UPF1 is located, we placed a DNA fragment coding for three copies of an influenza HA epitope in frame at the 3' end of the UPF1 ORF. Detection of the tagged product UPF1-3EP was achieved using commercially available 12CA5 monoclonal antibodies. We had previously found that a single copy of the same epitope placed at the same position in UPF1 provided an insufficient signal. It was visible on Western blots only when the singlytagged protein was overproduced. We also found an unacceptable level of cross-reaction with an endogenous yeast protein that has an apparent molecular weight of 51 k both by Western blotting and by immunofluorescent microscopy.
All of the problems with the single-epitope tagging system were avoided using the triple-epitope. UPF1-3EP was detected in protein extracts from a strain carrying one copy of UPF1-3EP on a centromeric plasmid. No significant cross-reaction was evident by Western blotting, immunofluorescent microscopy, or confocal microscopy. Furthermore, tagging the C-terminus provided another advantage by minimizing the chance of detecting incomplete, nascent UPF1-3EP polypeptides on polyribosomes. Nascent UPF1-3EP is released from polyribosomes soon after synthesis of the C-terminal epitopes. Any epitopes detected in association with polyribosomes are therefore likely to be located on full length UPF1-3EP protein molecules that have re-associated with polyribosomes.
The validity of our results depends on whether UPF1-3EP retains its function despite the addition of 37 amino acids to the C-terminus. We assayed UPF1-3EP function in strains lacking the normal UPF1 protein using three criteria: (1) the ability to suppress growth in an allo-frameshift suppression assay ( Figure  1 ; Culbertson et al., 1980) , (2) the ability to restore growth in medium containing lactate as the sole carbon source (Figure 4; Altamura et al., 1992) and, (3) the ability to reduce steady-state accumulation of his4-38 mRNA through accelerated decay (Leeds et al., 1991) . Our results show that UPF1-3EP is 86% (± 5%) as efficient as the wild-type UPF1 protein in promoting nonsense mRNA decay. This modest reduction in function is recessive. Because UPF1-3EP is functional, we assume that its cellular location is identical to wild-type UPF1.
Our results indicate that all of the detectable UPF1-3EP is found in the cytoplasm. We could not detect any UPF-3EP in the nucleus using three different approaches. UPFl-specific fluorescent antibody staining was absent in the region of the nucleus that stains with DAPI. Little overlap in differential fluorescent staining was detected when cells were double labeled with fluorescent antibodies that recognize UPF1-3EP and SEN1::,gal fusion protein that is distributed exclusively in the nucleoplasm. Finally, in cells double labeled with antibodies that recognize UPF1-3EP and the ER protein KAR2, no UPFl-3EP-specific fluorescence was observed inside the boundary of the nuclear envelope that is outlined by KAR2 staining in 80% of cells. Considering the strength of the cytoplasmic fluorescent signal obMolecular Biology of the Cell 622 served using the triple epitope tag, the evidence favors the view that the vast majority of UPF1-3EP is in the cytoplasm. Nonetheless, there could be a minor fraction of nuclear or nucleolar UPF1-3EP that is present at a concentration below the detection limits or that is refractory to antibody staining.
Cytochemical studies comparing the location of UPF1-3EP with the mitochondrial protein MAS2 suggest that there is little overlap in the distribution of these two proteins. The possible presence of some UPF1-3EP in the mitochondrion was further tested using a cellular fractionation procedure that separates mitochondria from other cellular components. A small amount of UPF1-3EP was detected in the mitochondrial fraction, but it was proteinase K sensitive and therefore located outside the mitochondria. The effects of UPF1 on mitochondrial mRNA splicing, which takes place inside the organelle, is therefore likely to be an indirect consequence of UPF1 function. UPF1 may affect the level of expression of a yet to be identified nuclear gene whose product is required for mitochondrial function. This view is plausible because it has already been shown that UPF1 affects the expression of some natural mRNAs (Leeds et al., 1991) .
UPF1 Associates with Polyribosomes
We assessed the potential association of UPF1 with polyribosomes by examining the behavior of UPF1-3EP and ribosomal protein Li in sucrose gradients. The distribution of both proteins exhibited similar changes using three different sets of conditions that alter the polyribosome profile. When cycloheximide was omitted, about 20% of both UPF1-3EP and LI shifted out of fractions containing polyribosomes and into fractions containing 80S ribosomal particles. When preparations were treated with RNase A, 65-85% of both UPF1-3EP and LI shifted from the polyribosomes to the fractions containing 80S ribosomal particles. Finally, when cells were shifted from a synthetic to a rich medium that supports more rapid growth, 20-30% of both UPF1-3EP and Li shifted into fractions containing polyribosomes. UPF1-3EP and Li may exhibit a similar shift due to an association of UPF1 with polyribosomes. Further experiments will be required to establish the molecular basis of the proposed association.
A variable proportion of UPF1-3EP was detected in fractions that do not contain ribosomal subunits, 80S ribosomal particles, or polyribosomes. In the presence of 50 ,ug/ml cycloheximide, about 20% of UPF1-3EP was found in fractions containing monomers, small aggregates, or small complexes. Less than 1% was found in these fractions when cycloheximide was omitted. RNase A treatment in the presence or absence of cycloheximide also caused up to 50% of UPF1-3EP to shift from the polyribosome fractions to the ribosome-free fractions. Combined with the observation that complete loss of UPF1 function confers cycloheximide hypersensitivity (Leeds et al., 1992) , we are considering the possibility that cycloheximide may inhibit the association of UPF1-3EP with polyribosomes either indirectly or by direct competition for a binding site on the 60S ribosomal subunit.
Yeast translational initiation factors, such as GCN2 (Ramirez et al., 1991) , behave in sucrose gradients as though they interact with ribosomes during translational initiation. GCN2 preferentially associates with 60S ribosomal subunits, 80S ribosomal particles, and polyribosomes during exponential growth and it cosediments with 40S and 60S ribosomal subunits when polyribosomes are disaggregated. These results suggest that GCN2 interacts with ribosomes during the translation initiation cycle (Ramirez et al., 1991) . By contrast, UPF1 may associate with polyribosomes after formation of an initiation complex. UPF1-3EP accumulates in fractions containing 80S ribosomal particles and polyribosomes, but not in fractions containing the 40S and 60S ribosomal subunits during exponential growth. When polyribosomes are disaggregated, UPF1-3EP co-sediments with 80S ribosomal particles, but does not appear to accumulate in fractions containing 40S or 60S ribosomal subunits. UPF1-3EP therefore behaves more like a translational elongation or termination factor.
Like other known translation factors that utilize GTP hydrolysis to dissociate from polyribosomes, UPF1 contains a consensus motif for GTP binding that has the potential to control cyclic binding and release of UPF1 from polyribosomes. It is generally thought that conformational differences between GDP-and GTP-bound forms of the translation factors influence the relative rates of association and dissociation of the factors from ribosomes. However, even if UPF1 binds GTP for a similar purpose, it differs from other known G-proteins that function in translation in that it is not required to support normal cell growth and therefore does not perform a function in protein synthesis that is essential for growth (Leeds et al., 1991) .
Functional Relationships between UPF1, Polyribosomes, and Nonsense mRNA Decay Although UPF1 function has been shown to be required in order for nonsense mRNA decay to occur, it has not yet been established that it plays a direct role in the decay pathway. Genetic evidence suggesting that a direct role is possible comes primarily from the analysis of both recessive and dominant mutations in UPF1.
Leeds et al. (1992) reported that the phenotypes of dominant point mutations in UPF1 resemble the phenotype of a recessive gene disruption that confers complete loss of function. Both types of alleles result Vol. 6, May 1995 623 in the stabilization of nonsense mRNAs. The strength of the dominant phenotype was found to depend on the dosage of the dominant allele relative to the wildtype allele (Leeds et al., 1992) . Nonsense mRNA decay was inhibited to a greater extent when a dominant allele was over-expressed relative to the wild-type allele. Dominant UPF1 mutations meet all of the criteria of the classical dominant-negative phenotype. A dominant-negative UPF1 protein might interfere with wild-type UPF1 function by one of two general mechanisms (Herskowitz, 1987) . It could act as a poison subunit by forming a nonfunctional multimer with wild-type UPF1 or with other proteins that interact with UPF1. Alternatively, it could bind a substrate of UPF1 more tightly than wild type and block UPF1 function by preventing access to a substrate. Dominant-negative UPF1 mutations map exclusively within a conserved sequence motif (Leeds et al., 1992) that shares similarity with proteins that have helicase and/or RNA-dependent NTPase activity (Koonin, 1993) . The identification of dominant-negative mutations exclusively in this region suggests the presence of a functional domain in UPF1 that has the potential to interact with RNA, and that this interaction is important in the underlying mechanism for the dominant-negative phenotype. The identity of the proposed RNA could provide a way to determine whether UPF1 performs a catalytic function in the nonsense mRNA decay pathway.
In the absence of more direct information regarding UPF1 function, we cannot definitively infer whether it associates with polyribosomes for the purpose of catalyzing a step in the nonsense mRNA decay pathway or whether it associates with polyribosomes to perform a function in translation that indirectly promotes nonsense mRNA decay. What is known is that the mRNA substrate for decay as well as UPF1, a potential catalyst of a step in the decay pathway, are both associated with polyribosomes (Leeds et al., 1991) . Given the uncertainty regarding UPF1 function, our finding that UPF1 is primarily cytoplasmic may not necessarily mean that nonsense mRNA decay is a cytoplasmic event. It remains possible that this type of decay occurs at the interface of the nucleus and cytoplasm as proposed by Belgrader et al. (1994) .
Northern blotting was used as an indirect way to measure the relative abundance of UPF1 to ribosomes. After controlling as much as possible for differences in hybridization efficiency, we found that ribosomal protein S3 and L3 mRNA accumulation was about 100-fold lower. Furthermore, the codon bias index of 0.21 for UPF1 (Leeds et al., 1992) is typical of genes expressed at a low level, whereas the codon bias indices for S3 and L3 (0.93 and 0.88, respectively) are typical of yeast genes expressed at a high level (Bennetzen and Hall, 1982) . Even assuming that the rates of translation of the three genes are similar, the possibility of 1:1 ratio of UPF1 to ribosomes seems unlikely. The evidence to date suggests that there are far fewer UPF1 molecules than ribosomes per cell. If UPF1 associates with polyribosomes to promote nonsense mRNA decay, it remains to be explained how those polyribosomes containing target mRNAs could be identified by UPF1 fast enough to affect the decay rate given the apparent low abundance of UPF1 relative to ribosomes. Some target mRNAs, such as his4-38 mRNA, have a half-life of 3-4 min (Leeds et al., 1991) , which indicates that the time interval may be too short for a relatively small number of UPF1 protein molecules to randomly scan polyribosomes for the presence of target mRNAs. This raises two possibilities. Polyribosomes or target mRNAs may be tagged in some way that allows for selective recognition, similar in principle to the way that proteins are tagged for degradation by ubiquitin. Alternatively, UPF1 may act downstream in the decay pathway and might require the presence of other, perhaps more abundant, proteins that associate with polyribosomes or target mRNAs first. Experiments designed to distinguish between these alternatives are currently in progress.
